Skip to main content

Table 2 Meta-analysis of the association between apolipoprotein E gene ε2/ε3/ε4 polymorphism and glaucoma *

From: Apolipoprotein E gene ε4ε4 is associated with elevated risk of primary open angle glaucoma in Asians: a meta-analysis

Groups

Sample size

Number of Studies

Test of association

Test of heterogeneity

Case

Control

OR(95% CI)

Z

P-value

Model

χ 2

P-value

I 2(%)

Overall

ε2 vs ε3

4765

4201

15

1.08(0.88-1.32)

0.74

0.46

R

20.83

0.08

37.6

 

ε2 carriers vs ε3ε3

2001

1804

14

1.02(0.79-1.33)

0.18

0.86

R

21.18

0.05

43.3

 

ε2ε2 vs ε3ε3

1688

1541

14

1.11(0.54-2.28)

0.28

0.78

F

3.51

0.83

0.0

 

ε4 vs ε3

4931

4364

15

1.14(0.86-1.51)

0.92

0.36

R

58.45

<0.0001

76.0

 

ε4 carriers vs ε3ε3

2146

1955

14

1.15(0.82-1.59)

0.81

0.42

R

50.80

<0.0001

74.4

 

ε4ε4 vs ε3ε3

1704

1549

14

1.66(0.99-2.78)

1.92

0.05

F

14.05

0.23

21.7

Controls in HWE

ε2 vs ε3

3994

3588

11

1.03(0.87-1.22)

0.36

0.72

F

11.02

0.27

18.3

 

ε2 carriers vs ε3ε3

1790

1597

11

0.93(0.71-1.22)

0.54

0.59

R

15.50

0.08

41.9

 

ε2ε2 vs ε3ε3

1525

1359

11

1.34(0.62-2.90)

0.73

0.46

F

2.05

0.92

0.0

 

ε4 vs ε3

4112

3722

11

1.10(0.83-1.47)

0.69

0.49

R

33.90

0.0002

70.5

 

ε4 carriers vs ε3ε3

1900

1723

11

1.04(0.77-1.42)

0.26

0.79

R

29.86

0.0009

66.5

 

ε4ε4 vs ε3ε3

1533

1367

11

1.41(0.80-2.50)

1.18

0.24

F

10.35

0.32

13.1

Caucasian

ε2 vs ε3

2516

2342

8

1.08(0.89-1.31)

0.74

0.46

F

7.70

0.36

9.1

 

ε2 carriers vs ε3ε3

996

963

7

1.07(0.84-1.36)

0.55

0.58

F

6.65

0.35

9.8

 

ε2ε2 vs ε3ε3

821

813

7

0.92(0.41-2.09)

0.20

0.84

F

2.74

0.60

0.0

 

ε4 vs ε3

2606

2468

8

0.96(0.81-1.13)

0.51

0.61

F

7.89

0.34

11.3

 

ε4 carriers vs ε3ε3

1079

1076

7

0.93(0.75-1.14)

0.73

0.46

F

4.62

0.59

0.0

 

ε4ε4 vs ε3ε3

823

822

7

0.92(0.47-1.77)

0.26

0.79

F

5.52

0.36

9.3

Asian

ε2 vs ε3

2249

1859

7

1.07(0.71-1.62)

0.32

0.75

R

13.05

0.02

61.7

 

ε2 carriers vs ε3ε3

1005

841

7

0.95(0.56-1.63)

0.18

0.86

R

14.41

0.01

65.3

 

ε2ε2 vs ε3ε3

867

728

7

2.08(0.45-9.63)

0.94

0.35

F

0.04

0.98

0.0

 

ε4 vs ε3

2325

1896

7

1.53(0.83-2.84)

1.36

0.17

R

48.44

<0.0001

87.6

 

ε4 carriers vs ε3ε3

1067

879

7

1.56(0.77-3.13)

1.24

0.21

R

45.75

<0.0001

86.9

 

ε4ε4 vs ε3ε3

881

727

7

5.22(1.85-14.68)

3.13

0.002

F

2.95

0.71

0.0

POAG (Caucasian)

ε2 vs ε3

1454

1404

6

1.02(0.80-1.30)

0.13

0.90

F

6.95

0.22

28.1

 

ε2 carriers vs ε3ε3

522

549

5

0.99(0.72-1.37)

0.05

0.96

F

5.92

0.20

32.5

 

ε2ε2 vs ε3ε3

426

457

5

0.79(0.26-2.44)

0.41

0.68

F

0.56

0.76

0.0

 

ε4 vs ε3

1522

1478

5

1.04(0.84-1.28)

0.34

0.74

F

6.56

0.26

23.8

 

ε4 carriers vs ε3ε3

581

613

5

1.01(0.76-1.33)

0.05

0.96

F

3.59

0.47

0.0

 

ε4ε4 vs ε3ε3

430

463

5

1.24(0.55-2.77)

0.52

0.60

F

3.05

0.38

1.6

POAG (Asian)

ε2 vs ε3

2091

1859

7

0.96(0.75-1.22)

0.34

0.73

F

6.27

0.28

20.2

 

ε2 carriers vs ε3ε3

953

841

7

0.78(0.48-1.27)

1.00

0.32

R

10.68

0.06

53.2

 

ε2ε2 vs ε3ε3

827

728

7

2.08(0.45-9.63)

0.94

0.35

F

0.04

0.98

0.0

 

ε4 vs ε3

2149

1896

7

1.45(0.82-2.55)

1.29

0.20

R

37.92

<0.0001

84.2

 

ε4 carriers vs ε3ε3

1000

879

7

1.45(0.76-2.76)

1.13

0.26

R

36.86

<0.0001

83.7

 

ε4ε4 vs ε3ε3

838

727

7

4.98(1.75-14.20)

3.01

0.003

F

3.01

0.70

0.0

  1. *POAG: primary open angle glaucoma; HWE: Hardy-Weinberg equilibrium; vs: versus; OR: odds ratio; CI: confidence interval; F: fixed effect model; R: random effect model.